PT91584A - Processo para a preparacao de uma composicao farmaceutica util para imunossupressao contendo um inibidor-activador de plasminogenio (pai-2) - Google Patents

Processo para a preparacao de uma composicao farmaceutica util para imunossupressao contendo um inibidor-activador de plasminogenio (pai-2)

Info

Publication number
PT91584A
PT91584A PT91584A PT9158489A PT91584A PT 91584 A PT91584 A PT 91584A PT 91584 A PT91584 A PT 91584A PT 9158489 A PT9158489 A PT 9158489A PT 91584 A PT91584 A PT 91584A
Authority
PT
Portugal
Prior art keywords
pai
inhibitor
preparation
pharmaceutical composition
immunosuppression
Prior art date
Application number
PT91584A
Other languages
English (en)
Other versions
PT91584B (pt
Inventor
Norbert Heimburger
Thomas Stief
Hans Ulrich Schorlemmer
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of PT91584A publication Critical patent/PT91584A/pt
Publication of PT91584B publication Critical patent/PT91584B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT91584A 1988-08-31 1989-08-30 Processo para a preparacao de uma composicao farmaceutica util para imunossupressao contendo um inibidor-activador de plasminogenio (pai-2) PT91584B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3829523A DE3829523A1 (de) 1988-08-31 1988-08-31 Verwendung von plasminogen-aktivator-inhibitor (pai-2) zur immunsuppression

Publications (2)

Publication Number Publication Date
PT91584A true PT91584A (pt) 1990-03-08
PT91584B PT91584B (pt) 1995-05-31

Family

ID=6361973

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91584A PT91584B (pt) 1988-08-31 1989-08-30 Processo para a preparacao de uma composicao farmaceutica util para imunossupressao contendo um inibidor-activador de plasminogenio (pai-2)

Country Status (9)

Country Link
EP (1) EP0356945B1 (pt)
JP (1) JPH02108633A (pt)
KR (1) KR900002791A (pt)
AT (1) ATE97576T1 (pt)
AU (1) AU616555B2 (pt)
DE (2) DE3829523A1 (pt)
DK (1) DK428089A (pt)
ES (1) ES2061842T3 (pt)
PT (1) PT91584B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
KR20010042402A (ko) * 1998-04-01 2001-05-25 로잘란드 앤 칼도르 피부 상처의 치료를 위한 프로테아제 억제제의 용도
AUPP508798A0 (en) * 1998-08-05 1998-08-27 Biotech Australia Pty Limited Method of treating psoriasis
EP1066834A3 (de) * 1999-07-08 2004-06-02 Thomas Dr. Stief Pharmazeutische Zusammensetzungen enthaltend ein phagozytenmodulierendes Agens
ATE297217T1 (de) 1999-10-27 2005-06-15 Alexandra Lucas Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
AUPQ380699A0 (en) * 1999-11-02 1999-11-25 Biotech Australia Pty Limited Protease inhibitors as modulators of periodontal wound healing
AU2001291579B2 (en) 2000-09-29 2006-08-31 Viron Therapeutics Inc. Use of serp- 1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
KR100550385B1 (ko) * 2002-11-11 2006-02-08 메타볼랩(주) 트랜스글루타미나아제를 포함하는 칸디다 속의 미생물과그의 숙주 세포 사이의 결합 저해제
JP4578067B2 (ja) * 2003-06-06 2010-11-10 宏 清水 局所医薬組成物
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
US4851345A (en) * 1985-01-14 1989-07-25 Terumo Kabushiki Kaisha Fibrinophilic urokinase complex and method for production thereof
DE3713272A1 (de) * 1987-04-18 1988-11-03 Behringwerke Ag Plasminogenaktivator-inhibitor, typ 2 (pai-2)
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva

Also Published As

Publication number Publication date
DE3829523A1 (de) 1990-03-01
EP0356945A3 (de) 1991-07-31
KR900002791A (ko) 1990-03-23
EP0356945A2 (de) 1990-03-07
PT91584B (pt) 1995-05-31
DK428089D0 (da) 1989-08-30
DE58906241D1 (de) 1994-01-05
DK428089A (da) 1990-03-01
ATE97576T1 (de) 1993-12-15
AU4090589A (en) 1990-03-08
EP0356945B1 (de) 1993-11-24
JPH02108633A (ja) 1990-04-20
AU616555B2 (en) 1991-10-31
ES2061842T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
DE3686410D1 (de) Stabilisierte zusammensetzungen von menschlichen aktivatoren des gewebeplasminogens.
AU4135289A (en) Pharmaceutically active combination
PH21591A (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition
PT85055A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ester metilico da levodopa
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ATE210983T1 (de) Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
AU567236B2 (en) Pharmaceutical formulation of tissue plasminogen activator
PT82066B (pt) Processo para preparacao de composicoes farmaceuticas contendo uma combinacao de flupirtina e de espasmoliticos com accao anticolinergica
PT91584A (pt) Processo para a preparacao de uma composicao farmaceutica util para imunossupressao contendo um inibidor-activador de plasminogenio (pai-2)
SE9402157L (sv) Framaceutisk komposition med analgetisk aktivitet
DK427989A (da) Anvendelse af transgluataminaser som immunosuppresiva
PT82499B (pt) Processo para a preparacao de inibidores de anidrase carbonica e de composicoes farmaceuticas que os contem
PT90127A (pt) Processo para a preparacao de composicoes farmaceuticas com accao analgesica que contem 4-aril-4-piperidino (ou pirrolidino ou hexa-hidroazepino)-carbinois ou os seus analogos heterociclicos
PT92228A (pt) Processo para a preparacao de uma formulacao oral liquida, contendo diclofenac
PT95735A (pt) Processo para a preparacao de morfolinois e de composicoes farmaceuticas que os contem
DK163639C (da) Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper
PT86292A (pt) Processo para a preparacao de uma composicao farmaceutica anti-hipertensora,contendo um activador de canal de potassio(por exemplo,cromacalina)e um inibidor de ace(por exemplo,enalapril)
ES2064652T3 (es) Derivados de naftaleno- y tetrahidronaftaleno-gem-difosfonato.
ES2082523T3 (es) Un medicamento de accion retardada que contiene ibuprofen y su empleo.
ZA866810B (en) A pharmaceutical composition for the treatment of high blood pressure
PT89350A (pt) Processo para a preparacao de uma combinacao sinergistica de inibidores de descarboxilase e de l-dopa e de composicoes farmaceuticas que a contem
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19941118

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19970531